课题基金 / 基金详情

U.S.-Australia Emerging Cancer Biomedical Technologies Workshop

U.S.-Australia Emerging Cancer Biomedical Technologies Workshop
美国-澳大利亚新兴癌症生物医学技术研讨会
批准号:
1735665
负责人:
Rafael Davalos
金额:
$2.7万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2018-06-30

项目摘要

项目成果

Rafael Davalos的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PI: Davalos, Rafael V.Proposal #:1735665This effort will enable an international workshop from June 13-15, 2017 in Arlington, Virginia, bringing together engineers and scientists to discuss emerging cancer biomedical technologies. The overarching goal of this international meeting is to understand the status of the field, specifically relating to topical areas of: biophotonics and imaging, cancer detection, cancer treatment, tissue engineering, cell therapeutics, drug delivery, biomedical engineering, and multi-scale modeling. This workshop will increase our scientific understanding serve as a catalyst for a large economic impact as these platforms are developed. The workshop will explore and develop opportunities for cutting-edge research spanning basic to translational collaborations between U.S. and Australian participants while also strategizing a future for cancer research internationally. The workshop will be limited to less than 100 participants and will focus on cutting-edge, emerging biomedical technologies applicable to cancer detection, treatment, and clinical studies. The collaborative sessions will bring together researchers, federal scientists and companies specializing in topical areas such as: biophotonics, epigenomics, genomics, genetic engineering, proteomics, nanotechnology, tissue engineering, single cell analysis technologies, imaging technologies, microfluidics, materials, and minimally invasive technologies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NSF/FDA SIR: Numerical heart model for irreversible electroporation ablation
Planning IUCRC Virginia Tech: Center for Cyber-Physical Systems for the Hospital Operating Room (CyBHOR)
I-Corps: Translation of High Frequency Irreversible Electroporation (H-FIRE) for Human Clinical Applications via the Veterinary Oncology Market
海外基金